Evidence map›Paper›PMID 41732093›Full record

ArticleG3 (Bethesda, Md.)2026

Detection of CRISPR-Cas-induced mutations in Daphnia.

Swatantra Neupane, Michael E Pfrender, Li Wang, Sen Xu

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Swatantra NeupaneDivision of Biological Sciences, University of Missouri, Columbia, MO 65211, USA.ORCID 0000-0003-4709-764X
Michael E PfrenderDepartment of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA.ORCID 0000-0001-6861-0655
Li WangDivision of Biological Sciences, University of Missouri, Columbia, MO 65211, USA.
Sen XuDivision of Biological Sciences, University of Missouri, Columbia, MO 65211, USA.ORCID 0000-0002-1304-9968

Funding

Understanding the origin of parthenogenesisR35GM133730 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI Sen Xu · 2019 to 2026
$2.7M
NIGMS NIH HHS R35 GM133730NIH HHS R35GM133730NSF Career program 2348390NSF EDGE program 2220696NSF EDGE program 2324639
6 · The paper itself

Abstract

CRISPR-Cas9 has established itself as a robust tool for conducting loss-of-function gene research in emerging model species, including the freshwater zooplankton Daphnia. However, sensitive detection of mutations, especially in genetic mosaic and pooled samples, remains a challenge. In this study, we evaluate 2 of the most widely used mutation screening techniques, the T7 Endonuclease I assay and fragment analysis for their sensitivity, accuracy, and practical use in detecting CRISPR-induced indels in 4 targeted genes, DNMT3A, DNMT3B, PERIOD2, and DMRT1 in Daphnia magna. Here, we show that T7 Endonuclease I, although it offers a quick and cost-effective screening method, often produces false positives, especially when examining pooled samples. Conversely, fragment analysis facilitates detecting allele size differences at a fine resolution, reproducibility in detecting indels, and distinguishing zygosity, and is more reliable as a method to detect mutation. Our comparative analyses convey the importance of carefully selecting the appropriate screening methods depending on research questions.

Indexed as

CRISPR-Cas SystemsDaphniaDaphnia magnaMutationAllelesAnimalsINDEL MutationReproducibility of ResultsDaphniafragment analysismutantsscreeningT7 endonuclease

Identifiers

PMID41732093
PMCPMC13148381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.